| Wearable Injectors market in terms of revenue was estimated to be worth $8.4 billion in 2023 and is poised to reach $15.1 billion by 2029, growing at a CAGR of 10.3% from 2023 to 2029 according to a latest report published by MarketsandMarkets™. The rising tide of chronic diseases – diabetes, cardiovascular conditions, autoimmune disorders, miniaturization, microfluidics, and sensor technology are in constant evolution, paving the way for smaller, smarter, and more user-friendly injectors. The shift towards home-based care creates a need for self-administered and easy-to-use medication delivery devices. The rise of biologics, complex protein-based drugs requiring specific administration methods, opens doors for new delivery technologies, compared to traditional syringes and vials, wearable injectors offer unmatched convenience and ease of use, Improved adherence, reduced hospitalizations, and lower healthcare costs is likely to grow the market. |
